Stay updated on Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision identifier changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:47:29.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the birinapant and pembrolizumab study is now displayed, with its study design, eligibility criteria, outcomes, locations, and record history. It states that the trial was terminated and enrollment stopped following a futility analysis.
    Difference
    57%
    Check dated 2026-11-11T01:51:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:13:03.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    An NIH transition notice was added above the ClinicalTrials.gov 403 error page, and the displayed site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:18:34.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:27:50.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the prior study record content and removing the trial details from view.
    Difference
    19%
    Check dated 2026-09-23T00:19:20.000Z thumbnail image

Stay in the know with updates to Birinapant and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Birinapant and Pembrolizumab in Solid Tumors Clinical Trial page.